NCT03702023

Brief Summary

The investigators are purposing a study to evaluate the use of acetaminophen given prior to an electrophysiology procedure and post procedural pain control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 10, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

February 8, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

July 2, 2019

Status Verified

June 1, 2019

Enrollment Period

1.3 years

First QC Date

August 23, 2018

Last Update Submit

June 28, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numerical rating scale measurement of pain in response to electrophysiology procedures and change in pain over time.

    A standard 0-10 numerical rating scale of pain (0=no pain, 10 = the worst possible pain) will be subjectively reported to nursing staff and recorded.

    The patients pain will be recorded prior to the procedure and then every one hour post procedure for four hours. Pain will then be recorded every four hours for a total of 24 hours or patient discharge from the hospital whichever comes first.

Secondary Outcomes (1)

  • Additional Pain Medication

    We will monitor the patients for additional doses of pain medication from the time their procedure is completed and the following 24 hours.

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

Patients in the intervention group with receive the study medication 1000mg acetaminophen orally one time prior to their scheduled electrophysiology procedure.

Drug: Acetaminophen

Placebo Oral Tablet

PLACEBO COMPARATOR

Patients in the control group will receive a placebo orally one time prior to their scheduled electrophysiology procedure.

Drug: Placebo Oral Tablet

Interventions

Intervention group will receive 1000 mg of acetaminophen

Also known as: Tylenol
Intervention Group

Control group will be given a placebo capsule.

Also known as: Placebo
Placebo Oral Tablet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Over 18
  • Weight: Greater than 50kg
  • Scheduled for an EP procedure
  • Be able to take oral medications
  • Provide signed written informed consent

You may not qualify if:

  • Have chronic pain requiring the use of chronic pain medications including narcotic pain medications or chronic acetaminophen use greater than seven consecutive days prior to the procedure
  • Known hypersensitivity to acetaminophen
  • Known or suspected history of alcohol or drug abuse/dependence within the previous 2 years
  • Known impaired liver function
  • Active pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ascension Genesys Hospital

Grand Blanc, Michigan, 48439, United States

Location

Related Publications (4)

  • January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28. No abstract available.

    PMID: 24682348BACKGROUND
  • Bode K, Breithardt OA, Kreuzhuber M, Mende M, Sommer P, Richter S, Doering M, Dinov B, Rolf S, Arya A, Dagres N, Hindricks G, Bollmann A. Patient discomfort following catheter ablation and rhythm device surgery. Europace. 2015 Jul;17(7):1129-35. doi: 10.1093/europace/euu325. Epub 2014 Dec 8.

    PMID: 25488958BACKGROUND
  • Wininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, Singla NK. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010 Dec;32(14):2348-69. doi: 10.1016/j.clinthera.2010.12.011.

    PMID: 21353105BACKGROUND
  • Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making. Can J Hosp Pharm. 2015 May-Jun;68(3):238-47. doi: 10.4212/cjhp.v68i3.1458.

    PMID: 26157186BACKGROUND

MeSH Terms

Interventions

Acetaminophen

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Michael Taipale, D.O.

    Ascension Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiology Fellow

Study Record Dates

First Submitted

August 23, 2018

First Posted

October 10, 2018

Study Start

February 8, 2019

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

July 2, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

No plans at this time to share IPD with other researchers

Locations